Robert Hazlett
Robert Hazlett
billion change company critical growth
It's at the margin. It's $3 billion and change of a $50 billion company, so it's not inconsequential, but is it critical to the growth of the company going forward? No.
investors meaningful risk
For investors in Pfizer, this is a meaningful event. This risk has been a significant overhang for some time.
confidence hard inspiring looking pull
It's not very confidence inspiring to pull your guidance, and because of that we're looking hard at our 2006 estimates.